Morning Market Movers
December 13, 2012 at 09:56 AM EST
Oncolytics Biotech (NASDAQ: ONCY ) surged 75.12% to $3.80 at 9:55 am. Oncolytics Biotech announced initial positive top line REOLYSIN data from the first endpoint in its double-blinded randomized Phase III clinical study in head and neck cancers. Telik (NASDAQ: TELK ) climbed 42.61% to $2.51. Telik announced the
